StockGuide AI
Suivre des actions
EN RU ES DE IT PT FR
Roche

Roche

Prix: 51.65

Entreprise et modèle économique

Roche is a global healthcare company specializing in pharmaceuticals and diagnostics. Its core products include prescription medications, particularly in oncology, immunology, and neuroscience, as well as diagnostic tools for various diseases. Major business segments are Pharmaceuticals and Diagnostics, with primary revenue sources stemming from drug sales and diagnostic testing services. The company is known for its strong research and development capabilities, contributing to its innovative product pipeline.

Profil d’investissement

Roche's investment profile is characterized by a balanced approach, appealing to investors seeking both growth and dividends. The company offers a stable dividend yield, making it attractive for income-focused investors, while its strong revenue growth indicates potential for capital appreciation. This combination positions Roche as suitable for those looking for a reliable investment with moderate risk.

Site officiel

Métriques fondamentales (expérimental)

BPA (TTM) — bénéfice par action des 12 derniers mois, $
2.73 OK
Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
90.4% ↑
Volatilité 20 j
1.8% stable
Rendement du dividende
3.1% modéré dernière date ex-dividende: 2026-03-13
Données FMP / FinFeed mises à jour: 2026-06-11
Reco: Acheter Potentiel: 67 Risque: 35 Mis à jour: 2026-06-13 02:58
Comment fonctionne la recommandation
Pourquoi l’IA pense cela:
Strong fundamentals and solid dividend yield support growth.

Suivre dans le portefeuille

Graphique des prix

Recommandation IA Prévision d’analyste Événement calendrier Signal positif Signal négatif Neutre / mise à jour Conserver / informatif B My buy S My sell
Changements de recommandation IA
Date Avant Après Raison
2026-06-05 02:47 Vendre Acheter Strong revenue growth, but mixed momentum signals.
2026-06-03 02:51 Conserver Vendre Weak momentum and high risk limit upside potential.
2026-06-01 02:49 Acheter Conserver Solid fundamentals, but mixed momentum signals present uncertainty.
Prévisions des analystes
Date Analyste Action Objectif Prix alors
2025-12-10 11:17 HSBC Objectif relevé 50 → 57 48.66
2025-10-02 09:07 HSBC Note relevée — → 50 44.83